[CLDX] YoY Quarter Result on 31-Mar-2009 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-May-2009
Financial Year
2009
Quarter
31-Mar-2009 [#Q1]
Profit Trend
QoQ- -3.37%
YoY- 65.19%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 2,433 2,516 3,713 3,732 147 1,182 3,706 -6.76%
PBT -13,083 -9,574 -6,245 -7,704 -22,131 -5,626 -2,599 30.88%
Tax -410 -268 -6,324 -165 29,419 -885 372 -
NP -13,516 -10,059 -6,582 -7,704 -22,131 -5,626 -2,971 28.69%
Tax Rate - - - - - - - -
Total Cost 15,949 12,575 10,295 11,436 22,278 6,808 6,677 15.60%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin -555.53 -399.80 -177.27 -206.45 -15,014.23 -475.92 -80.16 38.03%
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
EPS -4.04 -4.71 -3.11 -7.30 -32.78 -121.88 -7.21 -9.19%
EPS Diluted -4.04 -4.71 -3.11 -7.30 -32.78 -121.88 -7.21 -9.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.